Table of Contents
Form 6-K
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Report of Foreign Private Issuer
Pursuant to Rules 13a-16 or 15d-16 of
the Securities Exchange Act of 1934
Pursuant to Rules 13a-16 or 15d-16 of
the Securities Exchange Act of 1934
Dated: December 15th, 2006
ALTANA Aktiengesellschaft
(Translation of Registrant’s name into English)
Am Pilgerrain 15
D-61352 Bad Homburg v. d. Höhe
Federal Republic of Germany
(Address of principal executive offices)
D-61352 Bad Homburg v. d. Höhe
Federal Republic of Germany
(Address of principal executive offices)
Indicate by check mark whether the Registrant files or will file annual reports under cover Form
20-F or Form 40-F.
Form 20-F þ Form 40-F o
Indicate by check mark if the Registrant is submitting the Form 6-K in paper as permitted by
Regulation S-T Rule 101(b)(1): o
Indicate by check mark if the Registrant is submitting the Form 6-K in paper as permitted by
Regulation S-T Rule 101(b)(7): o
Indicate by check mark whether the Registrant by furnishing the information contained in this Form
is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the
Securities Exchange Act of 1934.
Yes o No þ
If “Yes” is marked, indicate below the file number assigned to the Registrant in connection with
Rule 12g3-2(b): 82-
TABLE OF CONTENTS
| SIGNATURES | ||||||||
Table of Contents
This Report on Form 6-K is hereby incorporated by reference into the Registrant’s Registration
Statements on Form S-8, dated September 13, 2002 (File No. 333-99485), dated September 24, 2003
(File No. 333-109074), dated September 24, 2004 (File No. 333-119240), and dated September 26, 2005
(File No. 333-128583).
This Report on Form 6-K contains:
| • | Press Release of December 14th, 2006 |
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly
caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| ALTANA Aktiengesellschaft |
||||
| Dated: December 15th, 2006 | By: | /s/ Hermann Küllmer | ||
| Name: | Dr. Hermann Küllmer | |||
| Title: | Chief Financial Officer and Member of the Management Board |
|||
| By: | /s/ Rudolf Pietzke | |||
| Name: | Dr. Rudolf Pietzke | |||
| Title: | General Counsel | |||
Table of Contents
Press release
|
ALTANA AG P.O. Box 1244 61282 Bad Homburg v.d.H. Herbert-Quandt-Haus Corporate Communications Am Pilgerrain 15 61352 Bad Homburg v.d.H. Germany P +49 (0) 6172 1712-160 F +49 (0) 6172 1712-158 pr@altana.de www.altana.com |
ALTANA obtains approval by antitrust authorities for sale of its pharmaceuticals business
Bad Homburg, December 14, 2006 — ALTANA AG (NYSE: AAA; FSE: ALT) has announced that the
European and U.S. antitrust authorities have approved the acquisition of ALTANA’s pharmaceuticals
business by Nycomed without conditions.
ALTANA AG announced the sale of ALTANA Pharma AG and its entire pharmaceuticals business to Nycomed
on September 21, 2006. Subject to the approval by the Extraordinary General Meeting of ALTANA AG on
December 19/20, closing of the transaction is expected by December 29, 2006, the transfer of the
business by the turn of the year.
Table of Contents
Page 2
This press release is also available on the Internet at www.altana.com.
For inquiries please contact:
Dr. Thomas Gauly
Head of Corporate Communications &
Investor Relations
Head of Corporate Communications &
Investor Relations
Media Relations:
P + 49 (0) 6172 1712-160
P + 49 (0) 6172 1712-150
F + 49 (0) 6172 1712-158
P + 49 (0) 6172 1712-160
P + 49 (0) 6172 1712-150
F + 49 (0) 6172 1712-158
Investor Relations:
P + 49 (0) 6172 1712-163
P + 49 (0) 6172 1712-165
F + 49 (0) 6172 1712-158
P + 49 (0) 6172 1712-163
P + 49 (0) 6172 1712-165
F + 49 (0) 6172 1712-158
Investor Relations USA:
P +1 212 974 98 00
F +1 212 974 61 90
P +1 212 974 98 00
F +1 212 974 61 90